Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Shenzhen New Industries Biomedical Engineering Co Ltd
Cash from Financing Activities
Shenzhen New Industries Biomedical Engineering Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Cash from Financing Activities
-¥568.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Cash from Financing Activities
-¥2.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Cash from Financing Activities
¥1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Cash from Financing Activities
-¥334.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Cash from Financing Activities
¥1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Cash from Financing Activities
¥4.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
See Also
What is Shenzhen New Industries Biomedical Engineering Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-568.6m
CNY
Based on the financial report for Dec 31, 2023, Shenzhen New Industries Biomedical Engineering Co Ltd's Cash from Financing Activities amounts to -568.6m CNY.
What is Shenzhen New Industries Biomedical Engineering Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-41%
Over the last year, the Cash from Financing Activities growth was -14%.